Vir Biotechnology (VIR) Price to Sales (2019 - 2026)
Vir Biotechnology's (VIR) Price to Sales was 6.25 for Q3 2026, down 86.7% from 47.08 a year earlier but up 9.9% from the prior quarter.
Powered by 
Analysis
Vir Biotechnology (VIR) Price to Sales (2019 - 2026) Analysis & Trends
For FY2025, Price to Sales at Vir Biotechnology was 12.27, down 9.4% from FY2024.
- By year, Price to Sales came in at 13.55 in FY2024 (-13.9%), 15.73 in FY2023 (+653.9%), 2.09 in FY2022 (-58.4%) and 5.01 in FY2021 (-88.8%).
- Five-year quarterly Price to Sales spans a low of 1.04 in Q3 2022 and a high of 47.08 in Q3 2025.
- Year over year, Price to Sales has now declined in each of the last four quarters, with growth averaging 38.2% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was Q3 2023 (growth of 917.6%); the low point was Q1 2022 (a decline of 98.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at 5.68 (Q2 2026), 22.04 (Q1 2026) and 12.27 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vir Biotechnology | 2.23 Bn | 313.19 Mn | 188,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.25 |
| Jun 30, 2026 | 5.68 |
| Mar 31, 2026 | 22.04 |
| Dec 31, 2025 | 12.27 |
| Sep 30, 2025 | 47.08 |
| Jun 30, 2025 | 36.84 |
| Mar 31, 2025 | 42.89 |
| Dec 31, 2024 | 13.55 |
| Sep 30, 2024 | 13.02 |
| Jun 30, 2024 | 15.41 |
| Mar 31, 2024 | 17.29 |
| Dec 31, 2023 | 15.73 |
| Sep 30, 2023 | 10.61 |
| Jun 30, 2023 | 6.71 |
| Mar 31, 2023 | 5.91 |
| Dec 31, 2022 | 1.99 |
| Sep 30, 2022 | 1.04 |
| Jun 30, 2022 | 1.54 |
| Mar 31, 2022 | 1.46 |
| Dec 31, 2021 | 5.01 |
API Access
Vir Biotechnology Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();